［1］ CHIDAMBARANATHAN-REGHUPATY S,FISHER PB,SARKAR D.Hepatocellular carcinoma (HCC):Epidemiology,etiology and molecular classification ［J］.Advances in Cancer Research,2021,149:1-61.
［2］ XIANG X,NIU YR,WANG ZH,et al.Cancer-associated fibroblasts:Vital suppressors of the immune response in the tumor microenvironment ［J］.Cytokine & Growth Factor Reviews,2022,67:35-48.
［3］ SONG M,HE J,PAN QZ,et al.Cancer-associated fibroblast-mediated cellular crosstalk supports hepatocellular carcinoma progression ［J］.Hepatology (Baltimore,Md),2021,73(5):1717-1735.
［4］ CHEN Y,MCANDREWS KM,KALLURI R.Clinical and therapeutic relevance of cancer-associated fibroblasts ［J］.Nature Reviews Clinical Oncology,2021,18(12):792-804.
［5］ TAN HX,XIAO ZG,HUANG T,et al.CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development ［J］.Cancer Biology & Therapy,2020,21(3):248-257.
［6］ GALBO PM,ZANG X,ZHENG D.Molecular features of cancer-associated fibroblast subtypes and their implication on cancer pathogenesis,prognosis,and immunotherapy resistance ［J］.Clinical Cancer Research,2021,27(9):2636-2647.
［7］ BIFFI G,TUVESON DA.Diversity and biology of cancer-associated fibroblasts ［J］.Physiological Reviews,2021,101(1):147-176.
［8］ COSTA A,KIEFFER Y,SCHOLER-DAHIREL A,et al.Fibroblast heterogeneity and immunosuppressive environment in human breast cancer ［J］.Cancer Cell,2018,33(3):463-479.e10.
［9］ JACKSON HW,FISCHER JR,ZANOTELLI VRT,et al.The single-cell pathology landscape of breast cancer ［J］.Nature,2020,578(7796):615-620.
［10］ KHAN KA,KERBEL RS.Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa ［J］.Nature Reviews Clinical Oncology,2018,15(5):310-324.
［11］ APTE RS,CHEN DS,FERRARA N.VEGF in signaling and disease:Beyond discovery and development ［J］.Cell,2019,176(6):1248-1264.
［12］ THOMPSON AI,CONROY KP,HENDERSON NC.Hepatic stellate cells:central modulators of hepatic carcinogenesis ［J］.BMC Gastroenterology,2015,15:63.
［13］ VOGEL A,MEYER T,SAPISOCHIN G,et al.Hepatocellular carcinoma ［J］.Lancet (London,England),2022,400(10360):1345-1362.
［14］ KAPS L,SCHUPPAN D.Targeting cancer associated fibroblasts in liver fibrosis and liver cancer using nanocarriers ［J］.Cells,2020,9(9):2027.
［15］ WU B,LIU DA,GUAN L,et al.Stiff matrix induces exosome secretion to promote tumour growth ［J］.Nature Cell Biology,2023,25(3):415-424.
［16］ CHO HJ,KIM B,KIM HJ,et al.Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment ［J］.European Radiology,2020,30(8):4182-4192.
［17］ WANG HM,HUNG CH,LU SN,et al.Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients［J］.Liver International,2013,33(5):756-761.
［18］ DHAR D,BAGLIERI J,KISSELEVA T,et al.Mechanisms of liver fibrosis and its role in liver cancer ［J］.Experimental Biology and Medicine (Maywood,NJ),2020,245(2):96-108.
［19］ MEHTA V,CHANDER H,MUNSHI A.Complex roles of discoidin domain receptor tyrosine kinases in cancer ［J］.Clinical & Translational Oncology,2021,23(8):1497-510.
［20］ KHAN GJ,SUN L,KHAN S,et al.Versatility of cancer associated fibroblasts:commendable targets for anti-tumor therapy ［J］.Current Drug Targets,2018,19(13):1573-1588.
［21］ LIU G,YANG ZF,SUN J,et al.The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth ［J］.Cellular Oncology (Dordrecht),2022,45(6):1435-1449.
［22］ CHEN S,MORINE Y,TOKUDA K,et al.Cancer-associated fibroblast-induced M2-polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor-1 pathway ［J］.International Journal of Oncology,2021,59(2):1-14.
［23］ RIGUAL MDM,SANCHEZ P,DJOUDER N.Is liver regeneration key in hepatocellular carcinoma development［J］.Trends in Cancer,2023,9(2):140-157.
［24］ LIU F,ZHANG W,YANG F,et al.Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling ［J］.Scientific Reports,2016,6:21260.
［25］ HE G,KARIN M.NF-κB and STAT3-key players in liver inflammation and cancer ［J］.Cell Research,2011,21(1):159-168.
［26］ GIANNELLI G,MAZZOCCA A,FRANSVEA E,et al.Inhibiting TGF-β signaling in hepatocellular carcinoma ［J］.Biochimica et Biophysica Acta,2011,1815(2):214-223.
［27］ SHEN X,LI N,LI H,et al.Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma ［J］.Journal of Cancer Research and Clinical Oncology,2010,136(11):1745-1754.
［28］ TOMIGUCHI M,YAMAMOTO Y,YAMAMOTO-IBUSUKI M,et al.Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer ［J］.Cancer Science,2016,107(4):491-498.
［29］ AHN S,LEE J,HONG M,et al.FGFR2 in gastric cancer:protein overexpression predicts gene amplification and high H-index predicts poor survival ［J］.Modern Pathology,2016,29(9):1095-1103.
［30］ ZUIVERLOON TC,TJIN SS,BUSSTRA M,et al.Optimization of nonmuscle invasive bladder cancer recurrence detection using a urine based FGFR3 mutation assay ［J］.The Journal of Urology,2011,186(2):707-712.
［31］ LIU J,CHEN S,WANG W,et al.Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways ［J］.Cancer Letters,2016,379(1):49-59.
［32］ XU H,ZHAO J,LI J,et al.Cancer associated fibroblast-derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1α/ZEB1 axis ［J］.Cell Death & Disease,2022,13(5):478.
［33］ LIU G,SUN J,YANG ZF,et al.Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis ［J］.Cell Death & Disease,2021,12(3):260.
［34］ LU L,HUANG J,MO J,et al.Exosomal lncRNA TUG1 from cancer-associated fibroblasts promotes liver cancer cell migration,invasion,and glycolysis by regulating the miR-524-5p/SIX1 axis ［J］.Cellular & Molecular Biology Letters,2022,27(1):17.
［35］ FANG T,LV H,LV G,et al.Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer ［J］.Nature Communications,2018,9(1):191.
［36］ QI Y,WANG H,ZHANG Q,et al.CAF-released exosomal miR-20a-5p facilitates HCC progression via the LIMA1-mediated β-catenin pathway ［J］.Cells,2022,11(23):3857.
［37］ LI YY,TAO YW,GAO S,et al.Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p ［J］.EBioMedicine,2018,36:209-220.
［38］ LI BL,LU W,QU JJ,et al.Loss of exosomal miR-148b from cancer-associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis ［J］.Journal of Cellular Physiology,2019,234(3):2943-2953.
［39］ ZHANG Y,ZHAO J,DING M,et al.Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis ［J］.Journal of Experimental & Clinical Cancer Research:CR,2020,39(1):282.
［40］ MONTERAN L,EREZ N.The dark side of fibroblasts:cancer-associated fibroblasts as mediators of immunosuppression in the tumor microenvironment ［J］.Frontiers in Immunology,2019,10:1835.
［41］ CHENG Y,LI H,DENG Y,et al.Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma ［J］.Cell Death & Disease,2018,9(4):422.
［42］ MAO X,XU J,WANG W,et al.Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment:new findings and future perspectives ［J］.Molecular Cancer,2021,20(1):131.
［43］ CHENG JT,DENG YN,YI HM,et al.Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation ［J］.Oncogenesis,2016,5(2):e198.
［44］ GOEHRIG D,NIGRI J,SAMAIN R,et al.Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer ［J］.Gut,2019,68(4):693-707.
［45］ DENG Y,CHENG J,FU B,et al.Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells ［J］.Oncogene,2017,36(8):1090-1101.
［46］ CHIAVARINA B,RONCA R,OTAKA Y,et al.Fibroblast-derived prolargin is a tumor suppressor in hepatocellular carcinoma ［J］.Oncogene,2022,41(10):1410-1420.
［47］ ZHANG Y,LAZARUS J,STEELE NG,et al.Regulatory T-cell depletion alters the tumor microenvironment and accelerates pancreatic carcinogenesis ［J］.Cancer Discovery,2020,10(3):422-439.
［48］ AMAKYE D,JAGANI Z,DORSCH M.Unraveling the therapeutic potential of the Hedgehog pathway in cancer ［J］.Nature Medicine,2013,19(11):1410-1422.
［49］ SHIN K,LIM A,ZHAO C,et al.Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors ［J］.Cancer cell,2014,26(4):521-533.
［50］ OZDEMIR BC,PENTCHEVA-HOANG T,CARSTENS JL,et al.Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival ［J］.Cancer Cell,2014,25(6):719-734.
［51］ LI H,COURTOIS ET,SENGUPTA D,et al.Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors ［J］.Nature Genetics,2017,49(5):708-718.